Plasma and cerebrospinal fluid levels of baclofen (lioresal®) at optimal therapeutic responses in spastic paresis
- 1 November 1974
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 23 (3), 473-484
- https://doi.org/10.1016/0022-510x(74)90163-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Sites of Action of a New Muscle Relaxant (Baclofen, Lioresal®, Ciba 34 647–Ba)Journal of International Medical Research, 1974
- DIFFERENCES IN EFFECTS IN GAMMA AND ALPHA SPASTICITY INDUCED BY THE GABA DERIVATIVE BACLOFEN (LIORESAL)Brain, 1973
- Baclofen in the Treatment of SpasticityBMJ, 1971
- A new agent for the control of spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1970
- GABA DERIVATIVE IN SPASTICITY (β-(4-Chlorophenyl)-γ-Aminobutyric Acid, Ciba 34.647-Bα)Acta Neurologica Scandinavica, 1970